Richter, Karin LouiseDreyer, GretaLindeque, B. GerhardBotha, M.H.2015-05-202015-05-202014-08Richter, KL, Dreyer, G, Lindeque, BG & Botha, MH 2014, 'HPV vaccine : can we afford to hesitate?', South African Medical Journal, vol. 104, no. 8, pp. 522-523.0256-9574 (print)2078-5135 (online)10.7196/SAMJ.8449http://hdl.handle.net/2263/45190Cervical cancer, caused by human papillomavirus (HPV) infection, is highly prevalent in sub-Saharan Africa. The estimated annual incidence of cervical cancer is 35/100 000 women, with 22.5/100 000 associated deaths. This is in stark contrast to the 6.6/100 000 cases and 2.7/100 000 deaths reported in developed countries such as the USA, where HPV vaccination has been available since 2006.en© 2014 Health & Medical Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0).Cervical canverHPV vaccineHuman papillomavirus (HPV)VaccinationArticle